Nurix Therapeutics Statistics
NASDAQ: NRIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.85-0.755 (-5.55%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nurix Therapeutics by the numbers
Nurix Therapeutics has a market capitalization of $1.40 billion based on 109.25M shares outstanding. Its trailing P/E ratio is 5.3. The stock trades 41.8% below its 50-day average and 36.0% below its 200-day average.
Average daily trading volume is 2.47M shares, or about $31.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRIX valuation vs. peer median
| Metric | NRIX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.40B | $1.41B | -0% |
| Avg. volume | 2.47M | 821.59K | +201% |
Peer median across 8 companies: TYRA, ANAB, ADRX, SRPT, KLRA, RAPP, DMRA, QURE.
Valuation
- Market cap
- $1.40B
- P/E (TTM)
- 5.29
- Price / sales (latest FY)
- 16.71
- EPS (TTM)
- $2.43
- Shares outstanding
- 109.25M
Price and trading
- Previous close
- 13.60
- Open
- 13.40
- Day range
- 12.83 – 13.67
- 52-week range
- 12.83 – 28.23
- 52-week change
- -23.33%
- Beta
- —
- Volume
- 2.43M
- Average volume
- 2.47M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 12, 2026
Additional statistics
- Market Cap
- 1.40B
- Pe
- 5.29
- Forward Pe
- -10.07
- Eps
- 2.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.23
- Week52 Low
- 12.83
- Avg Volume
- 2.47M
- Shares Outstanding
- 109.25M
- Ma50
- 22.07
- Ma200
- 20.06
- Earnings Date
- Oct 12, 2026
- Pct From52w High
- -54.50%
- Pct From52w Low
- 0.16%